Quak E - Search Results

1

Clinical applications of positron emission tomography in sarcoma management.

Quak E, van de Luijtgaarden AC, de Geus-Oei LF, van der Graaf WT, Oyen WJ. Quak E, et al. Expert Rev Anticancer Ther. 2011 Feb;11(2):195-204. doi: 10.1586/era.10.133. Expert Rev Anticancer Ther. 2011. PMID: 21342039 Review.

2

[Diarrhoea and fever in chemotherapy patients due to listeriosis].

Quak E, van Laarhoven HW, Bos H, Bouwhuis JW, van Herpen CM, van der Graaf WT. Quak E, et al. Ned Tijdschr Geneeskd. 2010;154:A1645. Ned Tijdschr Geneeskd. 2010. PMID: 20619037 Dutch.

3

FDG-PET/CT in a Patient with Poor-Risk Non-Seminoma Testis with Mature Teratoma and Secondary Gliosarcoma: Multimodality Imaging for Guiding Multimodality Treatment.

Quak E, Kovacs I, Oyen WJ, van der Graaf WT. Quak E, et al. Nucl Med Mol Imaging. 2015 Sep;49(3):237-40. doi: 10.1007/s13139-015-0321-9. Epub 2015 Feb 13. Nucl Med Mol Imaging. 2015. PMID: 26279698 Free PMC article.

4

Cost-effectiveness of one-stop-shop [¹⁸F]Fluorocholine PET/CT to localise parathyroid adenomas in patients suffering from primary hyperparathyroidism.

van Mossel S, Saing S, Appelman-Dijkstra N, Quak E, Schepers A, Smit F, de Geus-Oei LF, Vriens D. van Mossel S, et al. Among authors: quak e. Eur J Nucl Med Mol Imaging. 2024 Oct;51(12):3585-3595. doi: 10.1007/s00259-024-06771-1. Epub 2024 Jun 5. Eur J Nucl Med Mol Imaging. 2024. PMID: 38837058 Free PMC article.

5

Harmonizing SUVs in multicentre trials when using different generation PET systems: prospective validation in non-small cell lung cancer patients.

Lasnon C, Desmonts C, Quak E, Gervais R, Do P, Dubos-Arvis C, Aide N. Lasnon C, et al. Among authors: quak e. Eur J Nucl Med Mol Imaging. 2013 Jul;40(7):985-96. doi: 10.1007/s00259-013-2391-1. Epub 2013 Apr 6. Eur J Nucl Med Mol Imaging. 2013. PMID: 23564036 Free PMC article. Clinical Trial.

6

The importance of harmonizing interim positron emission tomography in non-Hodgkin lymphoma: focus on the Deauville criteria.

Quak E, Hovhannisyan N, Lasnon C, Fruchart C, Vilque JP, Musafiri D, Aide N. Quak E, et al. Haematologica. 2014 Jun;99(6):e84-5. doi: 10.3324/haematol.2014.104125. Epub 2014 Feb 28. Haematologica. 2014. PMID: 24584350 Free PMC article. No abstract available.

7

18F-FDG PET/CT in Hepatosplenic Gamma-Delta T-Cell Lymphoma.

Quak E, Salaun V, Le Naoures C, Fruchart C. Quak E, et al. Clin Nucl Med. 2015 Sep;40(9):730-1. doi: 10.1097/RLU.0000000000000876. Clin Nucl Med. 2015. PMID: 26053728

8

Harmonizing FDG PET quantification while maintaining optimal lesion detection: prospective multicentre validation in 517 oncology patients.

Quak E, Le Roux PY, Hofman MS, Robin P, Bourhis D, Callahan J, Binns D, Desmonts C, Salaun PY, Hicks RJ, Aide N. Quak E, et al. Eur J Nucl Med Mol Imaging. 2015 Dec;42(13):2072-82. doi: 10.1007/s00259-015-3128-0. Epub 2015 Jul 30. Eur J Nucl Med Mol Imaging. 2015. PMID: 26219870 Free PMC article.

9

Does PET SUV Harmonization Affect PERCIST Response Classification?

Quak E, Le Roux PY, Lasnon C, Robin P, Hofman MS, Bourhis D, Callahan J, Binns DS, Desmonts C, Salaun PY, Hicks RJ, Aide N. Quak E, et al. J Nucl Med. 2016 Nov;57(11):1699-1706. doi: 10.2967/jnumed.115.171983. Epub 2016 Jun 9. J Nucl Med. 2016. PMID: 27283930 Free article. Clinical Trial.

10

Subdiaphragmatic Lymph Nodes Uptake on 18F-FDG PET/CT After COVID-19 Vaccination in the Thigh.

Quak E, Morel A, Faudemer J, Levy C, Ciappuccini R. Quak E, et al. Clin Nucl Med. 2022 Mar 1;47(3):275-276. doi: 10.1097/RLU.0000000000003941. Clin Nucl Med. 2022. PMID: 34661560 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41 results

Search Page

Filters